January 26, 2024
  • The company has played a key role in the safe and efficient transport of vaccines to the Autonomous Communities.
  • Moreover, it tackles other challenges such as ensuring the cold chain of medicines and vaccines from origin to destination.


Logista, one of the largest logistics operators in Europe, has distributed more than 8.5 million vaccines during the six weeks of the vaccination campaign in the various Autonomous Communities. Logista has had to deal with a number of challenges to guarantee the correct supply, for which it relies on the collaboration of different businesses within the company itself.


Through Logista Pharma, a leading distributor for pharmaceutical and healthcare companies that serves more than 25,000 pharmacies in Spain and Portugal, it distributes more than 10 million doses of vaccines per year. Logista Pharma relies on the group’s transport companies to deliver orders, ensuring full operational integration, real-time physical and thermal traceability, with the highest quality standards and the use of state-of-the-art information systems.


In the transport of vaccines, it is critical to maintain a controlled temperature throughout the logistics process, ensuring the cold chain is unbroken from origin to destination. For this purpose, Logista Pharma enjoys the collaboration of Logista Parcel which, through its ‘Frío Farma’ service, transports thermolabile products that require thermal control between +2˚C and +8˚C, such as vaccines and insulins, and of NACEX through its NACEXpharma service, for urgent shipments involving strict temperature control by means of reusable isothermal packaging.


Another key aspect is compliance with the most stringent security regulations, including TAPA (Transported Asset Protection Association), GDP (Good Distribution Practice), and IFS (International Featured Standards). Logista ensures compliance above and beyond the standards required by these certifications. These regulations provide a solid framework to ensure the integrity and safety of cargoes, especially when they involve such sensitive products as vaccines. In the case of Logista Freight, the scale of the value of vaccine transport is between 20 and 30 million euros. In 2023, 80% of vaccine transports were made beyond our borders, 48% were exports and more than 20% were imports, both to countries such as Switzerland, France, Germany, Italy and Poland, mainly. The remaining of the vaccine transports were between European countries, such as Germany-Italy, France-Belgium, Italy-France, Switzerland-Slovenia, among others.


“At Logista we work every day to overcome great challenges. We assume a great responsibility on every journey to ensure that temperature-sensitive medicines reach their final destination in optimum condition. It is therefore essential to guarantee safety and quality at all stages of the transport,” Logista emphasised.


About Logista – www.logista.com

Logista is one of the largest logistics operators in Europe and specialises in distribution to local channels. It regularly serves almost 200,000 points of sale in Spain, France, Italy, Portugal, the Netherlands and Poland and offers the best and fastest market access to a wide range of convenience products, pharmaceuticals, electronic top-up, books, publications, tobacco and lotteries, among others. It is also notable for being the largest transport network in Spain, which is also certified in food safety.   


Logista has a team of highly qualified professionals made up of more than 7,450 direct employees and a large number of collaborators such as Nacex franchisees, Logista Parcel delegates, drivers, etc. Employees and collaborators all work focused on serving their customers in the most efficient way and adapted to their needs.